NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities


Thursday, March 18, 2010
 
Teva Pharmaceutical Industries Limited (TEVA) to Acquire Ratiopharm for Nearly $5 Billion    More...

Novelos Therapeutics, Inc. (NVLT) Discontinues Current Development Program for NOV-002 in NSCLC; Primary and Secondary Endpoints Not Met in Phase 3 Trial    More...

250 Jobs Gone as Warner Chilcott, PLC (WCRX) Exits Mason, Ohio    More...

Alzheimer Drug Test Result From Johnson & Johnson (JNJ) May Be Pushed Back to 2012    More...

UK, Spain Close to Approving GW Pharmaceuticals's Cannabis Drug    More...

Somaxon Pharmaceuticals, Inc. Announces FDA Approval of Silenor(R) (Doxepin) For The Treatment Of Insomnia    More...

US FDA Staff Says Novartis AG and Astellas Pharma Inc. May Need Wider Eczema Caution for Kids; New Reported Cases of Cancer and Infection    More...

OriGene Technologies, Inc. Raises $16 Million    More...

 
More Breaking News


 
 

 Market Summary

 
Baldness 'Could Be Good For Your Health' Say University of Washington Scientists    More...

Eli Lilly and Company (LLY) (JOBS) Gets Rights to Sell Testosterone Drug from Acrux Limited in Deal Worth up to $335 Million    More...

Dynavax Technologies Corporation (DVAX) Gets Going-Concern Warning; Auditors Express Doubts on Company's Financial Position    More...

Medivation, Inc. (MDVN) (JOBS) Loses $54.8 Million in 2009    More...

AstraZeneca PLC (AZN) (JOBS) Says Will be Picky in Emerging Markets    More...

4-Antibody AG Announces a Long-Term Collaboration With Boehringer Ingelheim Corporation for Therapeutic Antibodies; 4-Antibody AG will Receive Payments of up to EUR 177.5 Million    More...

Erectile Dysfunction Is Strong Predictor Of Fatal Heart Ailments, University of Saarland Study Finds    More...

One Gene Lost = One Limb Regained? The Wistar Institute Scientists Demonstrate Mammalian Regeneration Through a Single Gene Deletion    More...

Novartis Corporation (NVS)'s Drug Tekturna Fails to Help After Heart Attack According to Study    More...

Promedior Closes $12 Million Series C Financing    More...

 
More News

Join the GenePool

     
 
 
 Advanced Search     

 
Genes Linked to Ulcerative Colitis Identified At Cedars-Sinai Medical Center    More...
Anti-Obesity Drugs Unlikely To Provide Lasting Benefit According To University of Liverpool Scientists    More...
Hypnotherapy 'Can Help' Irritable Bowel Syndrome, Gloucestershire Royal Hospital Study    More...
Selenium Protects Men Against Diabetes, University of Montpellier Study Suggests    More...
New Attack On Cancer Forces Cells To Grow Old And Die, University of Texas MD Anderson Cancer Center Study    More...
Lipidemia Improves with Growth Hormone Tx, King's College London Study    More...
Drug Dramatically Reduces Nausea and Vomiting in Bone Marrow Transplant Patients, Loyola University Study    More...
Age Likely A Factor In Colon Cancer Chemotherapy, Harvard Medical School Study    More...
 
More Featured News




 
The Boehringer Ingelheim group of companies is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, the privately–owned company currently has nearly 39,800 employees and 135 affiliated companies spread around the globe. Boehringer Ingelheim is research-driven and dedicated to the discovery, development, manufacture and marketing of innovative human and animal health care products.

Show me jobs for this employer
 
Feature Employer
 
Top 5 Reasons Job Hunters Fail    More...

Second Battle: How to Prepare for an Interview    More...

Seven Tips for Working for a Younger Boss    More...

Standout Letters to Cover Your Bases    More...

From Job Hopping to Career Monogamy    More...

Climbing Your Way Out of a Career Setback    More...

Sound Advice for Those Switching Jobs    More...

LinkedIn: Why Your Career Might Depend On It    More...

The Grounded Edge - Thoughts On Your Career And Job Search - Your Sixth Sense    More...

Promoting Yourself on LinkedIn    More...

 
More Career Tips